Keyphrases
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
100%
Patients with COVID-19
75%
Prone Ventilation
50%
COVID-19
31%
Extracorporeal Membrane Oxygenation Support
30%
Adult Respiratory Distress Syndrome
29%
Adverse Events
25%
National Cohort Study
25%
Coronavirus Disease (COVID)
25%
Pulmonary Effects
25%
Severe Acute Respiratory Distress Syndrome
25%
Real-time Performance
25%
Intensive Care
25%
6-Month Outcome
25%
Mannan Antigen
25%
T2Candida
25%
Multicenter Observational Study
25%
Candida Mannan
25%
Stewardship Program
25%
Superinfection
25%
Antifungal Stewardship
25%
Esophagogastroduodenoscopy
25%
Invasive Candidiasis
21%
Technical Skills
20%
Pulmonary Aspergillosis
18%
Cytomegalovirus
18%
Antifungal Therapy
17%
Endoscopist
15%
Risk of Death
12%
Ventilator-associated Pneumonia
12%
Bacteremia
12%
Dynamic Compliance
11%
Competencies
10%
Denmark
8%
Median Time
6%
Poor Prognosis
6%
Medical Files
6%
Logistic Regression Analysis
6%
Odds Ratio
6%
Confidence Interval
6%
In-hospital Mortality
6%
Herpes Simplex Virus
6%
Landmark Identification
5%
Pathology Identification
5%
Antigen Screening
5%
Internal Structure
5%
Sensitivity Specificity
5%
Evidence-based Approach
5%
Validation Studies
5%
Cronbach's alpha
5%
Medicine and Dentistry
Extracorporeal Membrane Oxygenation
100%
COVID-19
75%
Cohort Analysis
50%
Acute Respiratory Distress Syndrome
50%
Prone Position
50%
Observational Study
25%
Esophagogastroduodenoscopy
25%
Adverse Event
25%
Coronavirinae
25%
Superinfection
25%
Virus Infection
25%
Lung Aspergillosis
15%
Cytomegalovirus
15%
Ventilator-Associated Pneumonia
10%
Bacteremia
10%
Symptom
5%
Hospital Mortality
5%
Conjugated Linoleic Acid
5%
Diagnosis
5%
Odds Ratio
5%
Herpes Simplex Virus
5%
Logistic Regression Analysis
5%
Systemic Candidiasis
5%
